Africa (WHO region) vs Azerbaijan: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Azerbaijan
100.0%
in 2024
Africa (WHO region) rank
2nd
Azerbaijan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Azerbaijan
How they compare
Azerbaijan currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 14 shared years of data; in 2011 it was Azerbaijan ahead.
Africa (WHO region) ranks 2nd and Azerbaijan ranks 1st of 11 groups.
Across the 2 decades both report, Africa (WHO region) averaged higher in 1 and Azerbaijan in 1.
Head to head by decade
| Decade | Africa (WHO region) | Azerbaijan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.7% | 73.8% | 3.9% | Africa (WHO region) |
| 2020s | 93.2% | 98.2% | 5.0% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Azerbaijan?
- Azerbaijan, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Azerbaijan?
- 4.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Africa (WHO region) and Azerbaijan?
- 14 years are reported by both, from 2011 to 2024.
- How do Africa (WHO region) and Azerbaijan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Azerbaijan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.